2,3 We sought to understand whether patients prescribed these medications were at an increased risk of thyroid cancer in the five years after their initial diabetes diagnosis compared to patients prescribed insulin, another frequently prescribed medication for the treatment of type 2 diabetes
However, the long-term treatment with GLP-1RAs may reduce the insulin levels in both T2DM (122) and prediabetic patients (123), owing to the glycemic normalization and increased insulin sensitivity in these patients
Notably, ILC2 proportions were comparable between IL-33 alone and IL-33 plus melatonin and Luzindole groups ( Figures 2K, L ), yet BALF concentrations of IL-5 ( Figures 2M ) and IL-13 ( Figures 2N ) remained significantly reduced with melatonin treatment, again indicating dampened ILC2 activity rather than altered ILC2 abundance
Research from 2021 suggests that dietary changes promoting the bodys natural release of GLP-1 could be useful for managing obesity and type 2 diabetes
The most frequently reported side effects include nausea (which typically improves over the first few weeks), constipation, and reduced appetite